CHU de Besançon
Besançon, France
Location status: Recruiting
NCT Number: NCT06112509
The purpose of this study is to evaluate the vestibular effects of gamma-knife radiosurgery, as part of the treatment of vestibular schwannoma.
Interested in participating?
Request Info18 year–90 year
All sexes
Interventional
Not applicable
Besançon, France
Location status: Recruiting
Vestibular schwannoma is a benign tumor located on the vestibulocochlear nerve. It represents 6 to 8% of intracranial tumors, 80% of ponto-cerebral angle tumors and its frequency is 13 cases per million inhabitants per year.
The main symptoms related to the development of vestibular schwannoma are unilateral deafness of perception, unilateral tinnitus, unilateral vestibular deficit vertigo, facial paralysis.
Management is divided into 3 options: monitoring, surgery and gamma-knife radiosurgery.
This study will focus on gamma-knife radiosurgery. The objective of this treatment is to stabilize the evolution of schwannoma.
This study aims to describe the vestibular effects of radiosurgery.
Healthy volunteers accepted: Yes
Only the study team can determine whether someone qualifies for participation.
Inclusion criteria
Exclusion criteria
Interrogation, videonystagmoscopy, videonystagmography, video-head-impulse-test
Time frame: 1 month before gamma-knife radiosurgery
Videonystagmography: Results of caloric tests = Intervestibular deficit (in percentage)
Time frame: After gamma-knife radiosurgery at 6 month or 12 month or 18 month or 2 years or 3 years depending on the history of the treatment
Videonystagmography: Results of caloric tests = Intervestibular deficit (in percentage)
Time frame: 1 month before gamma-knife radiosurgery
Dizziness Handicap Inventoryquestionnaire (DHI questionnaire)
Time frame: After gamma-knife radiosurgery at 6 month or 12 month or 18 month or 2 years or 3 years depending on the history of the treatment
Dizziness Handicap Inventoryquestionnaire (DHI questionnaire)
Contact information is provided by the study sponsor or research team.
Mylene ABISSE, MD
CONTACT
POZET Astrid
CONTACT
Centre Hospitalier Universitaire de Besancon
Other
Evolution of Vestibular Function After Treatment of a Vestibular Schwannoma by Gamma-knife
Acronym: EVERS
OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.
View the official ClinicalTrials.gov record (opens in a new tab)This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.
Published trials that share one or more normalized conditions with this study.
NCT03079999
Acoustic Neuroma, Congenital, Hereditary, and Neonatal Diseases and Abnormalities
Stanford, California, United States
View Trial DetailsNCT01199978
Acoustic Neuroma, Cranial Nerve Diseases
Boston, Massachusetts, United States
View Trial DetailsNCT04241679
Acoustic Neuroma, Asymmetric Sensorineural Hearing Loss
St Louis, Missouri, United States
View Trial DetailsNCT00863122
Acoustic Neuroma, Auditory Tumor
Los Angeles, California, United States
View Trial Details